
TRADING UPDATES: Further progress at Blencowe and Rockfire mines
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:...
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:...
Read more(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Monday that KYE Pharmaceuticals has submitted a new drug submission to Health Canada, for the regulatory rev...
Read more(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported total 2021 revenue of £1.5m in a trading update on Thursday, in line with market expectations....
Read more(Alliance News) - Shield Therapeutics PLC's shares tumbled on Thursday after a trading update revealed a substantial, but expected, fall in revenue....
Read more(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Wednesday, with KYE Pharmaceuticals in Ca...
Read moreShield Therapeutics signs license agreement in Canada for lead product...
Read more(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics updated the market on progress made on payer coverage of 'Accrufer' in the United States on Thursday....
Read moreAIM WINNERS & LOSERS: Wressle boosts Europa Oil, Egdon and Union Jack...
Read more(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Monday that Dr Jose Menoyo is joining its senior executive team as vice-president and chief medical officer,...
Read moreEXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec...
Read more(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported first-half revenues of £0.5m in its interim results on Tuesday, falling from £8.9m year-on-year....
Read moreAIM WINNERS & LOSERS: Sunrise results good; Surface gets brake deal...
Read moreShield Therapeutics shares fall as swings to loss in first half...
Read moreTRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE...
Read more(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Thursday, with Korea Pharma in South Kore...
Read more